BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2010
View Archived Issues
Bristol-Myers Squibb claims new lysophospholipid S1P1 receptor agonists
Read More
Abbott discloses new calcium channel blockers
Read More
Takeda discovers new PARP inhibitors
Read More
Incyte presents new tyrosine kinase inhibitors
Read More
Intellikine claims new PI3K and mTOR inhibitors
Read More
Merck KGaA discloses new MetAP 2 inhibitors
Read More
Riluzole exhibits cardioprotective activity in vivo
Read More
Alectos and Merck & Co. to codevelop O-GlcNAcase modulators for AD
Read More
FDA approves ella tablets for emergency contraception
Read More
LIPO-102 reduces abdominal fat in phase IIa study
Read More
Siltuximab shows promise in phase I trial in Castleman's disease
Read More
U.S. scientists describe new magnetic nanoparticles for multimodal imaging
Read More
Avasimibe reduces beta-amyloid burden in model of Alzheimer's disease
Read More
Briakinumab is safe and efficacious in phase II and III trials in psoriasis
Read More
Biofrontera obtains manufacturing and distribution license for pharma products
Read More
LifeCycle Pharma to conduct phase III LCP-Tacro trial in de novo kidney transplantation
Read More
NIDA awards grant to Selecta Biosciences for nicotine vaccine development
Read More
Antiherpes nanoviricides are efficacious in cell culture
Read More
Green Cross obtains marketing approval for peramivir in South Korea
Read More
US WorldMeds acquires Solstice Neurosciences
Read More
NextWave and Tris Pharma to collaborate on CNS drug development
Read More
ValiRx to develop CRT's prostate cancer candidate VAL-201
Read More
FDA proposes to withdraw marketing approval for midodrine hydrochloride
Read More
MMV contributes patents to support neglected tropical disease research
Read More
Morphotek begins phase I MORAb-028 trial in advanced melanoma
Read More